WOLVERINE TRADING, LLC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 157 filers reported holding CLOVIS ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
WOLVERINE TRADING, LLC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q2 2022$259,000
+108.9%
151,633
+101.4%
0.00%
Q1 2022$124,000
-47.5%
75,300
-8.9%
0.00%
Q4 2021$236,000
-62.2%
82,700
-40.2%
0.00%
Q3 2021$625,000
-50.2%
138,267
-35.5%
0.00%
-100.0%
Q2 2021$1,254,000
-12.7%
214,339
+1.2%
0.00%0.0%
Q1 2021$1,436,000
+43.6%
211,760
+4.2%
0.00%0.0%
Q4 2020$1,000,000
-2.4%
203,265
+17.8%
0.00%
-33.3%
Q3 2020$1,025,000
+12.5%
172,562
+33.1%
0.00%
+50.0%
Q2 2020$911,000
+122.7%
129,600
+26.9%
0.00%
+100.0%
Q3 2019$409,000
-75.7%
102,102
-9.7%
0.00%
-80.0%
Q2 2019$1,682,000
-27.7%
113,125
+20.7%
0.01%
-28.6%
Q1 2019$2,326,000
-2.7%
93,695
-29.6%
0.01%0.0%
Q4 2018$2,391,000
-13.6%
133,090
+41.3%
0.01%
+16.7%
Q3 2018$2,767,000
-36.2%
94,200
+14.6%
0.01%
-40.0%
Q2 2018$4,340,0000.0%82,2080.0%0.01%0.0%
Q1 2018$4,340,000
-64.1%
82,208
-53.7%
0.01%
-77.3%
Q4 2017$12,073,000
-36.4%
177,548
-22.9%
0.04%
-38.9%
Q3 2017$18,972,000
-27.5%
230,240
-19.0%
0.07%
-40.5%
Q2 2017$26,156,000
+86.1%
284,308
+27.0%
0.12%
+57.1%
Q1 2017$14,055,000
+467.4%
223,811
+213.0%
0.08%
+541.7%
Q3 2016$2,477,000
+83.2%
71,500
-20.3%
0.01%
+71.4%
Q2 2016$1,352,00089,7570.01%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
Palo Alto Investors LP 3,997,826$10,834,0000.69%
Ikarian Capital, LLC 1,112,669$3,016,0000.45%
Versant Venture Management, LLC 101,855$276,0000.15%
Virtus ETF Advisers LLC 60,836$165,0000.06%
EMFO, LLC 21,500$58,0000.05%
QVT Financial LP 505,000$1,369,0000.05%
QVT Financial LP 505,000$1,369,0000.05%
PINNACLE ASSOCIATES LTD 706,336$1,914,0000.03%
State of Wyoming 25,419$69,0000.03%
XTX Topco Ltd 20,920$57,0000.03%
View complete list of CLOVIS ONCOLOGY INC shareholders